iShares U.S. Medical Devices ETF
Price through Oct 1 · Flows through Sep 30. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.
The fund will invest at least 80% of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET −$2.2B OVER THIS RANGE
Money keeps arriving — +$217M of net inflows over the past month, about 6.3% of the fund's asset base, while the price has returned -18.5% so far this year. At 0.40% a year it is not the cheapest way in — FDHT has a reported fee of 0.39%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | ABTABBOTT LABORATORIES | 17.92% | $96.69 | -2.2% | ||
| 2 | ISRGINTUITIVE SURGICAL | 14.94% | $401.24 | -1.3% | ||
| 3 | MDTMEDTRONIC | 11.44% | $86.44 | +0.2% | ||
| 4 | DXCMDEXCOM | 4.52% | $86.23 | -0.1% | ||
| 5 | IDXXIDEXX LABORATORIES | 4.62% | $517.75 | -0.9% | ||
| 6 | SYKSTRYKER | 4.51% | $272.96 | -0.9% | ||
| 7 | BDXBECTON DICKINSON & | 4.51% | $178.07 | -0.5% | ||
| 8 | EWEDWARDS LIFESCIENCES | 4.56% | $85.19 | -1.3% | ||
| 9 | RMDRESMED | 4.44% | $221.15 | +0.0% | ||
| 10 | BSXBOSTON SCIENTIFIC | 4.35% | $43.23 | -1.0% | ||
| 11 | GEHCGE HEALTHCARE TECHNOLOGIES | 4.15% | $63.98 | -2.1% | ||
| 12 | STESTERIS | 2.84% | $209.34 | -0.3% | ||
| 13 | ZBHZIMMER BIOMET HOLDINGS | 2.41% | $88.06 | -0.9% | ||
| 14 | PENPENUMBRA | 1.73% | $318.00 | -0.1% | ||
| 15 | BAXBAXTER INTERNATIONAL | 1.68% | $23.64 | -1.5% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 57| 1 week | -1.8% |
| 1 month | -6.7% |
| 3 months | +1.3% |
| 6 months | -3.7% |
| YTD | -18.5% |
| 1 year | -14.9% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$78M |
| 1 month | +$217M |
| 3 months | +$264M |
| YTD | +$89M |
| 1 year | −$186M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 17.9% of the book; the top ten carry 76%. Spread across 51+ names, it behaves like roughly 12 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MDT MEDTRONIC | $4M | $11M |
| BSX BOSTON SCIENTIFIC | $1M | $8M |
| SYK STRYKER | $2M | $5M |
| ISRG INTUITIVE SURGICAL | $2M | $4M |
| ABT ABBOTT LABORATORIES | $1M | $1M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IHI on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -37bp on fee · 12× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -37bp on fee · 5× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -36bp on fee · 10× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -36bp on fee · 7× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -36bp on fee · 5× the assets · +$412M in over the month | Head-to-head |